Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Patton

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 29, 2017
A National Survey of Assertive Outreach Treatment Services for People Who Frequently Attend Hospital due to Alcohol-Related Reasons in EnglandStephanie Fincham-Campbell, Andreas Kimergård, Amy Wolstenholme, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|July 1, 2015
Replacement of Promethazine With Ondansetron for Treatment of Opioid- and Trauma-Related Nausea and Vomiting in Tactical Combat Casualty CareDana J Onifer, Frank K Butler, Kirby Gross, et al.
Lancet (London, England)|October 12, 2004
Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised controlled trialMike J Crawford, Robert Patton, Robin Touquet, et al.
Entropy (Basel, Switzerland)|December 3, 2020
Adiabatic Quantum Computation Applied to Deep Learning NetworksJeremy Liu, Federico M Spedalieri, Ke-Thia Yao, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferaseAlan B Cooper, Corey L Strickland, James Wang, et al.
Urologic Oncology|May 24, 2005
A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancerEric Winquist, Malcolm J Moore, Kim N Chi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 4, 2017
Screening for At-Risk Alcohol Consumption in Primary Care: A Randomized Evaluation of Screening ApproachesSimon Coulton, Veronica Dale, Paolo Deluca, et al.
Plos One|June 13, 2019
Adolescent perspectives about their participation in alcohol intervention research in emergency care: A qualitative exploration using ethical principles as an analytical frameworkEllen Lynch, Ruth McGovern, Catherine Elzerbi, et al.
Journal of Medicinal Chemistry|August 23, 2002
Exploring the role of bromine at C(10) of (+)-4-[2-[4-(8-chloro-3,10-dibromo- 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidinyl]-2- oxoethyl]-1-piperidinecarboxamide (Sch-66336): the discovery of indolocycloheptapyridine inhibitors of farnesyl protein transferaseArthur G Taveras, Cynthia Aki, Jianping Chao, et al.
BMC Public Health|April 18, 2015
Linked randomised controlled trials of face-to-face and electronic brief intervention methods to prevent alcohol related harm in young people aged 14-17 years presenting to Emergency Departments (SIPS junior)Paolo Deluca, Simon Coulton, M Fasihul Alam, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 29, 2017
A National Survey of Assertive Outreach Treatment Services for People Who Frequently Attend Hospital due to Alcohol-Related Reasons in EnglandStephanie Fincham-Campbell, Andreas Kimergård, Amy Wolstenholme, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|July 1, 2015
Replacement of Promethazine With Ondansetron for Treatment of Opioid- and Trauma-Related Nausea and Vomiting in Tactical Combat Casualty CareDana J Onifer, Frank K Butler, Kirby Gross, et al.
Lancet (London, England)|October 12, 2004
Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised controlled trialMike J Crawford, Robert Patton, Robin Touquet, et al.
Entropy (Basel, Switzerland)|December 3, 2020
Adiabatic Quantum Computation Applied to Deep Learning NetworksJeremy Liu, Federico M Spedalieri, Ke-Thia Yao, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferaseAlan B Cooper, Corey L Strickland, James Wang, et al.
Urologic Oncology|May 24, 2005
A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancerEric Winquist, Malcolm J Moore, Kim N Chi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 4, 2017
Screening for At-Risk Alcohol Consumption in Primary Care: A Randomized Evaluation of Screening ApproachesSimon Coulton, Veronica Dale, Paolo Deluca, et al.
Plos One|June 13, 2019
Adolescent perspectives about their participation in alcohol intervention research in emergency care: A qualitative exploration using ethical principles as an analytical frameworkEllen Lynch, Ruth McGovern, Catherine Elzerbi, et al.
Journal of Medicinal Chemistry|August 23, 2002
Exploring the role of bromine at C(10) of (+)-4-[2-[4-(8-chloro-3,10-dibromo- 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidinyl]-2- oxoethyl]-1-piperidinecarboxamide (Sch-66336): the discovery of indolocycloheptapyridine inhibitors of farnesyl protein transferaseArthur G Taveras, Cynthia Aki, Jianping Chao, et al.
BMC Public Health|April 18, 2015
Linked randomised controlled trials of face-to-face and electronic brief intervention methods to prevent alcohol related harm in young people aged 14-17 years presenting to Emergency Departments (SIPS junior)Paolo Deluca, Simon Coulton, M Fasihul Alam, et al.
Pageof 4